Search clinical trials for: neoSTX
Total 1 results
-
Charles BerdeCompletedSafety of Neosaxitoxin in Healthy VolunteersUnited States
Sponsors and Collaborators
- Paulo Sérgio Gomes Nogueira Borges
- Lilly PharmaceuticalCompany
- Sudimplant SAS - Groupe TBR
- Plethora Solutions Ltd
- Gunkang Pharmaceuticals, Inc
- S-Biotek Holding ApS
- Rivierduinen, Centre for Personality disorders Jelgersma
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Julian Taylor Green
- United States Department of Defense (DOD)
- Arsha Vidya Tirtha
- Eurotrials Brasil Consultores Cientificos Ltda
- Oblikue Consulting
- University of Applied Sciences Jena
- Iyad Naeem Muhammad, PhD
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Foshan Sanshui District People's Hospital
- Korea Otsuka International Asia Arab
- View Full List
Medical Conditions
- Visual Attention Span Deficit
- Anemia Acute
- Puberty, Delayed
- Gray Platelet Syndrome
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Thyroid and Parathyroid Surgery
- Advance Directive Completion
- Huntington Chorea
- Chemotherapy-Induced Neutropenia
- Blepharospasm of Both Eyelids
- Immunologically-induced Lung Disease
- Deformity Flexion
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Vibration; Exposure
- Malaria,Falciparum
- Testicular Teratoma
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Brain Tumor, Primary
- Serum Albumin Low
- Hypothermia Following Anesthesia, Sequela
- View Full List
Drug Interventions
- F520
- Furmonertinib 160 mg
- Vosaroxin
- Celecoxib
- S-Adenosyl-Methionine
- Cytisine
- Acalabrutinib in combination with VR
- Mineralocorticoid receptor antagonist
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Pegfilgrastim
- MMV390048 120mg
- Bimatoprost 0.03% eye drops
- Standard medical therapy
- Sorafenib
- Ebselen
- ABY-035 i.v.
- Rovalpituzumab tesirine
- Pemetrexed
- Oxycodone
- Cyanoacrylate
- View Full List
CROs by country
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Egypt
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Morocco
- Contract Research Organizations in Pakistan
- Contract Research Organizations in South Africa
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Tanzania
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in Venezuela
- CRO list by country